No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
CYBN250117P10000
- 1.35
- +0.10+8.00%
15min DelayClose Jan 10 16:00 ET
1.35High1.15Low
1.15Open1.25Pre Close2 Volume5.29K Open Interest10.00Strike Price250.00Turnover160.20%IV2.70%PremiumJan 17, 2025Expiry Date1.11Intrinsic Value100Multiplier4DDays to Expiry0.24Extrinsic Value100Contract SizeAmericanOptions Type-0.7213Delta0.2173Gamma6.59Leverage Ratio-0.0614Theta-0.0008Rho-4.75Eff Leverage0.0032Vega
Intraday
- 5D
- Daily
News
Cybin Inc. Achieves Breakthroughs in Mental Health Treatment
Cybin Highlights 2024 Progress, Launches Phase 3 Study for CYB003 to Treat Major Depressive Disorder
Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025
Psychedelic Drug Developer Lykos Could Get Lifeline From Former Tesla Board Member
Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
Cybin Files $650M Mixed Securities Shelf